Skip to main content

$10M Genome X Prize Will Go to First Team to Map 100 Human Genomes in 10 Days

NEW YORK (GenomeWeb News) — The X Prize Foundation today announced its $10 million Archon X Prize for Genomics, which will go to the first team to create a technology that can map 100 human genomes in 10 days.

According to the Foundation, the prize “is designed to usher in a new era of personalized preventative medicine.”

Three teams are currently enrolled in the competition: VisiGen Biotechnologies, led by Susan Hardin; 454 Life Sciences, led by CEO Christopher McLeod; and a group comprising the Westheimer Institute for Science and Technology, the Foundation for Applied Molecular Evolution, and Firebird Biomolecular Sciences. This group will be led by Steve Benner.
“Many other companies have inquired and more teams are expected to register soon,” the X Prize Fundation said.
The prize was announced at a press conference today at the National Press Club in Washington, DC. On hand were Craig Venter; Francis Collins; Anousheh Ansari, the first female private space explorer and co-founder and chairman of Prodea Systems; Sharon Terry, president and CEO of the Genetic Alliance; Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturing Association; and Stewart Blusson, president of Archon Minerals, which became the title sponsor of the prize after a “generous multi-million dollar” donation by Blusson.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.